Summary
DNA-content and size of the nuclear areas in different zones of malignant melanomas of different histological types and in dysplastic naevi were measured in order to provide information on the histogenesis and proliferative behaviour of human malignant melanoma. The results were compared with those from normal epidermis, common naevi, and reactive melanocytic hyperplasias. The mitotic index of melanomas -divided into different topographic zones in an analogous way - was also determined. The DNA-histographs of all naevi and reactive melanocytic hyperplasias showed a diploid maximum, but the dysplastic naevi had a larger proportion of nuclei with hyperdiploid and tetraploid DNA-content, indicating an increased proliferative activity. The mean values (X) of nuclear areas in dysplastic naevi (DN) were about the same as in common naevi (CN) and slightly lower than in superficial spreading melanomas (SSM). The coefficient of variability (cv) as an indicator of anisokaryosis was markedly higher in DN (27.8) and SSM (29.3) than in CN (20.2). In DNA-content we found similar results: almost no difference in mean values, but DN taking an intermediate position between CN and SSM with respect to cv (CN: 12.3; DN: 21.0; SSM: 36.6). There was no unequivocal evidence in these data for DN being a precancerous stage. Superficial melanomas with a nodular component (“SSM/NM”) differed from SSM and NM by increased DNA-content and greater variability of nuclear areas and showed the clearest features of malignancy in their DNA-histographs. The mitotic indices had rather low values in SSM and intraepidermal marginal zones of “SSM/NM” on one hand and markedly higher values in NM and nodular parts of “SSM/NM” on the other. The highest mitotic counts were found in the three investigated metastases.
Similar content being viewed by others
References
Ackerman AB (1980) Malignant melanoma: a unifying concept. Hum Pathol 11:591–595
Ackerman AB (1981) Pathology of malignant melanoma. Masson Publ Inc., New York
Ackerman AB (1982) Disagreements about classification of malignant melanomas. Am J Dermatopathol 4:447–452
Boehm N, Sandritter W (1975) DNA in human tumours: a cytophotometric study. Curr Top Pathol 60:151–219
Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902–908
Clark WH, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705–726
Clark WH, Mastrangelo MJ, Ainsworth AM, Berd D, Bellet RE, Bernardino EA (1977) Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res 24:267–338
Crucioli V, Stilwell J (1982) The histogenesis of malignant melanoma in relation to pre-existing pigmented lesions. J Cutan Pathol 9:396–404
Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH (1980) Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 46:1787–1794
Greene MH (1984) Dysplastic nevus syndrome. Hosp Pract 91–108
Kraemer K (1983) Dysplastic nevi as precursors to hereditary melanoma. Dermatol Surg Oncol 9:619–622
Kraemer KH, Greene MH, Tarone R, Elder DE, Clark WH, Guerry D (1983) Dysplastic naevi and cutaneous melanoma risk. Lancet 2:1076–1077
Lee JAH (1983) Epidemiology of malignant melanoma: 10 years progress. Pigment Cell 6:1–21
Magnus K (1981) Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary tumor site. Cancer 48:2329–2335
Manocha SL, Steele HD, Stich HF (1969) The mosaic composition of the DNA content of the epidermal carcinomas of man. Z Krebsforsch 72:144–154
McKie RM (1981) Which moles matter? The association between melanocytic naevi and malignant melanomata. Brit J Dermatol 105:607–609
Nowell PC (1978) Tumors as clonal proliferation. Virchows Arch B Cell Path 29:145–150
Rhodes AR, Harrist TJ, Day CL, Mihm MC, Fitzpatrick TB, Sober AJ (1983) Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 9:563–574
Schmoeckel C, Braun-Falco O (1978) Prognostic index in malignant melanoma. Arch Dermatol 114:871–873
Sober AJ, Day CL, Fitzpatrick TB, Lew RA, Kopf AW, Mihm MC (1983) Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients. J Invest Dermatol 80:53–55
Whang-Peng J, Chretien P, Knutsen T (1970) Polyploidy in malignant melanoma. Cancer 25:1216–1223
Author information
Authors and Affiliations
Additional information
Arbeitsgemeinschaft Malignes Melanom Eppendorf AMME
We gratefully acknowledge the generous support of the Hamburger Stiftung zur Förderung der Krebsbekämpfung
Rights and permissions
About this article
Cite this article
Schmiegelow, P., Schroiff, R., Breitbart, E. et al. Malignant melanoma - its precursors and its topography of proliferation. Vichows Archiv A Pathol Anat 409, 47–59 (1986). https://doi.org/10.1007/BF00705406
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00705406